The University of New Mexico Hospital entered a three‑year sole‑source contract with Biocomposites, Inc. for the purchase of Stimulan, an absorbable calcium‑sulfate antibiotic carrier designed to manage surgical dead space and reduce infection risk. The product is proprietary, with the vendor claiming it is the only FDA‑approved calcium matrix offering the broad surgical applicability required by the hospital. The contract is valued at $100,000, fixed‑price, and includes an option to renew under state procurement guidelines.
• Product: Stimulan – calcium‑sulfate carrier pre‑loaded with antibiotics for bone and soft‑tissue surgery.
• Vendor: Biocomposites, Inc. (Wilmington, NC) – sole supplier of this proprietary formulation.
• Scope: Supply of Stimulan for a three‑year period, with quantity sufficient for the hospital’s surgical services, at a total contract amount of $100,000.